View
213
Download
0
Category
Preview:
Citation preview
1
VTE Protocol
Presented by:Selina Baskins, RNQuality Coordinator
2
Each Risk Factor Represents 1 Point
•Age 41-60 years•Minor surgery planned•Hx of prior major surgery (<1 month)•Varicose veins•Hx of inflammatory bowel disease•Swollen legs (current)•Obesity (BMI>25kg/m2)•AMI•CHF•Sepsis•Serious lung disease including pneumonia
3
Each Risk Factor Represents 1 Point
Abnormal pulmonary function (COPD) Medical patient currently at bed rest Oral contraceptives Pregnancy or postpartum (<1month) Hx of unexplained stillborn infant, recurrent spontaneous abortion (>3), premature birth with toxemia, or growth-restricted infant
4
Each Risk Factor Represents 2 Points
Age 61-74 years Arthroscopic surgery Malignancy (present or previous) Major surgery (over 45 minutes) Laparascopic surgery (over 45 minutes) Patient confined to bed (>72 hours) Immobilizing plaster cast (<1 month) Central venous access
5
Each Risk Factor Represents 3 Points
Age ≥ 75 years Hx of VTE/PE Family Hx of thrombosis Blood/bone marrow dyscrasias * Thrombophilic condition ** Heparin induce thrombocytopenia
6
Each Risk Factor represents 5 Points
Elective major lower extremity arthroplasty Hip, pelvis, or leg fracture Stroke Multiple trauma Acute spinal cord injury (paralysis
7
Contraindications
Contraindications to pharmacologic prophylaxis i.e. active bleeding, current or history of heparin induced
thrombocytopenia, platelet count < 100,000
Contraindications to sequential compression devices, i.e. severe peripheral arterial disease, CHF, acute/superficial
VTE Other contraindications
8
Standard of Care for assessed Risk Score: IF INTERVENTIONS HAVE NOT BEEN ORDERED, CALL MDFOR ORDERS!
0-1 Low Risk = Early and aggressive ambulation
2 Moderate Risk Lovenox 40 mg subcutaneous daily
(Choose one) Lovenox 30 mg subcutaneous daily if CrCl less than 30
Graduated compression stockings thigh, knee high
Sequential compression device 3-4 High Risk Lovenox 40 mg
subcutaneous daily AND Sequential compression device
9
Standard of Care for assessed Risk Score: IF INTERVENTIONS HAVE NOT BEEN ORDERED, CALL MD FOR ORDERS (Cont’d)
(Choose one) Lovenox 30 mg subcutaneous daily AND Sequential compression device if CrCl less than 30
5 or more Very High Lovenox 40 mg subcutaneous daily, Sequential compression device AND graduated
Risk compression stocking Lovenox 30 mg subcutaneous daily if
CrCl less than 30, Sequential compression device
AND graduated compression stocking
10
Other instructions
If the patient received epidural anesthesia, do not start Lovenox until 24 hours after establishment of stable hemostasis
If the patient has an epidural postoperatively, do not start Heparin/LMWH until epidural ha
11
QUESTIONS????
Recommended